Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_assertion type Assertion NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_head.
- NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_assertion description "[These results suggest (1) characteristic phenotype and reduced IGF2 expression in the epimutation-positive placentas; (2) similarities and differences in the epigenetic control of the IGF2-H19 domain between leukocytes and placentas; (3) a positive role of the IGF2 expression level, as reflected by the methylation index, in the determination of body and placental growth in epimutation-positive patients, except for the brain where IGF2 is expressed biallelically; (4) involvement of placental dysfunction in prenatal growth failure; and (5) relevance of both (epi)genetic factor(s) and environmental factor(s) to SRS in epimutation-negative patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_provenance.
- NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_assertion evidence source_evidence_literature NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_provenance.
- NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_assertion SIO_000772 18607558 NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_provenance.
- NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_assertion wasDerivedFrom befree-2016 NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_provenance.
- NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_assertion wasGeneratedBy ECO_0000203 NP680713.RARigduKCcF0P1MXww9WaRhEvwCjHRRwC5V4okJDS6SpU130_provenance.